- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06437561
Report of Ten Cases of Venous Aneurysm in Extremities
Venous Aneurysm: a Case Series and Review of Literature
Study Overview
Status
Detailed Description
A vascular aneurysm is defined as the focal dilatation of a vessel. Aneurysm is classically used for arterial dilatations, although dilatations can occur in any part of the vascular system including veins. Venous aneurysms are not common in general, but with the increase in the use of duplex ultrasound, the number of cases diagnosed with venous aneurysms has recently increased. Venous aneurysms are more common in the lower limbs, and in the lower limbs, the involvement of the deep venous system is much more than the superficial venous system. According to reports, 77% of venous aneurysms are present in the lower limbs, of which 57% are in the deep venous system and 1.5% in the superficial venous system.
Considering their rarity, venous aneurysms may cause diagnostic challenges in some cases.
The importance of these aneurysms, especially in the lower limbs, which inherently have relative stasis due to the opposite flow direction of gravity, is that by creating venous stasis and whirlwind blood flow inside the aneurysm, they increase the susceptibility to clotting. Also, due to dysfunction of the pigeon nest valves, they cause chronic venous insufficiency. Although clot formation and subsequent pulmonary embolism are more common in deep venous aneurysms, cases of pulmonary embolism secondary to superficial venous aneurysms of the lower limbs have also been reported.
Complications caused by chronic venous insufficiency are more common in aneurysms that occur at the main junctions of superficial and deep veins, including saphenous femoral and saphenous popliteal junctions.
Considering the possible complications mentioned about venous aneurysms, these aneurysms need treatment, regardless of their location, and although in the superficial system, surgical resection is the most commonly recommended method, other surgical methods such as aneurysmectomy and primary repair, resection, and graft interposition, and also endovascular methods have been used. Of course, in case of insufficiency in the venous system, specific treatment of the cause of insufficiency (such as stripping of the large saphenous vein) is necessary in addition to the treatment of the aneurysm.
Regarding the follow-up after the treatment of aneurysms of the superficial system, most articles have recommended short-term treatment with anticoagulants and control of the superficial and deep systems through color doppler.
In this case series, we present 10 cases of venous aneurysms and discuss their presentation, diagnosis, and management.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Golestan
-
Gorgan, Golestan, Iran, Islamic Republic of, 4917956808
- Pezhman Kharazm, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
• Clinical diagnosis of venous aneurysm
Exclusion Criteria:
• Patient's non-consent
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
clinical presentation of extremity venous aneurysms
Time Frame: 6 years
|
different clinical presentations of extremity venous aneurysms and their prevalence
|
6 years
|
|
age distribution of extremity venous aneurysms
Time Frame: 6 years
|
prevalence of extremity venous aneurysms in different ages
|
6 years
|
|
location distribution of extremity venous aneurysms
Time Frame: 6 years
|
prevalence of extremity venous aneurysms in upper vs. lower limbs as well as left side vs. right side
|
6 years
|
|
sex distribution of extremity venous aneurysms
Time Frame: 6 years
|
prevalence of extremity venous aneurysms in both sexes
|
6 years
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 114099
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vascular Diseases
-
Leiden University Medical CenterRecruitingVascular Disease,PeripheralNetherlands
-
Boston Scientific CorporationRecruitingPeripheral Vascular DiseasesUnited States, Australia, Taiwan, Thailand, Austria, Germany, Canada, France, China, Spain, Poland
-
Midwest Cardiovascular Research FoundationCompletedPeripheral Vascular DiseaseUnited States
-
W.L.Gore & AssociatesActive, not recruitingPeripheral Vascular DiseasesGermany, Netherlands, France, Italy, Spain
-
The Methodist Hospital Research InstituteNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPeripheral Vascular DiseasesUnited States
-
SensomeCompletedPeripheral Vascular DiseaseBelgium
-
Rijnstate HospitalCompletedPeripheral Vascular DiseasesNetherlands
-
AmgenCompletedChorioretinal Vascular DiseaseUnited States
-
Duke UniversityTerminatedRetinal Vascular DiseaseUnited States
-
Terumo Europe N.V.CompletedPeripheral Vascular Disease | Hemostasis | Vascular Closure | Endovascular ProcedureBelgium, France, Germany